These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1707106)

  • 1. End-organ protection and antihypertensive therapy. Introduction.
    Bühler FR
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():vii-viii. PubMed ID: 1707106
    [No Abstract]   [Full Text] [Related]  

  • 2. Does left ventricular mass decrease during antihypertensive therapy?
    Drayer JI
    Arch Intern Med; 1985 Sep; 145(9):1583-4. PubMed ID: 3161483
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 4. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of hypertensive hypertrophy.
    Motz W; Strauer BE
    Scand J Clin Lab Invest Suppl; 1989; 196():62-71. PubMed ID: 2530623
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diltiazem: its place in the antihypertensive armamentarium.
    Fagan TC
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S26-31. PubMed ID: 1725539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the efficacity and tolerance of diltiazem LP 300 mg in 2000 hypertensive patients (alone or combined with an angiotensin converting enzyme inhibitor].
    Amar J; Joire JE; Salvador M
    Ann Cardiol Angeiol (Paris); 1999 Jan; 48(1):69-75. PubMed ID: 12555361
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive treatment and remission of left ventricular hypertrophy. Critical study].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():39-43. PubMed ID: 2150473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
    Carré A; Joire JE; Mounier-Vehier C; Lequeuche B
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effect of diltiazem administered once and twice daily.
    Mooser V; Waeber B; Nussberger J; Brunner HR
    J Hum Hypertens; 1988 Dec; 2(4):257-60. PubMed ID: 3236328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What is safe in the therapy of hypertensive heart disease?].
    Motz W; Strauer BE
    Internist (Berl); 1985 Dec; 26(12):750-64. PubMed ID: 2867983
    [No Abstract]   [Full Text] [Related]  

  • 13. [Course of hypertension and the potentials for regression].
    Shkhvatsabaia IK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):5-12. PubMed ID: 6212068
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities of reverse development of left-ventricular hypertrophy in hypertension].
    Bakhshaliev AB; Akhmetzianova EKh; Gadzhiev RF; Teboeva RV
    Klin Med (Mosk); 1989 Mar; 67(3):10-7. PubMed ID: 2526273
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the tolerance and effectiveness of Diltiazem LP 300 mg in hypertensive patients with chronic renal insufficiency].
    Bernadet-Monrozies P; Poilleux E; Suc JM
    Ann Cardiol Angeiol (Paris); 1998 Oct; 47(8):589-94. PubMed ID: 9809145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [General therapy of arteriosclerosis].
    Siedek H
    Wien Klin Wochenschr; 1969 Jun; 81(25):464-6. PubMed ID: 5809151
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension.
    Rudzite VK; Vitols AV; Liepinja DJ; Silava AK
    Cor Vasa; 1990; 32(1):56-63. PubMed ID: 2140318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem-induced left ventricular mass regression in hypertensive patients.
    Weiss RJ; Bent B
    J Clin Hypertens; 1987 Jun; 3(2):135-43. PubMed ID: 2956372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenomedullin as a potent antioxidative and antiatherosclerotic substance.
    Shimosawa T; Fujita T
    Drug News Perspect; 2005 Apr; 18(3):185-9. PubMed ID: 15915220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regression of left ventricular hypertrophy by a prolonged anti-hypertensive treatment].
    Sonaglioni G; Floris B; Franchetta G; Palestini N; Verdecchia P
    G Ital Cardiol; 1982; 12(6):428-35. PubMed ID: 6219030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.